Farmax India Limited reported unaudited standalone and consolidated earnings results for the first quarter ended June 30, 2016. For the quarter, on standalone basis, the company reported net sales/income from operations of INR 23.155 million compared to INR 48.190 million a year ago. Loss before interest and exceptional items was INR 10.213 million compared to INR 25.112 million a year ago. Loss before tax was INR 10.216 million compared to INR 25.141 million a year ago. Net loss after tax and extraordinary was INR 10.216 million compared to INR 25.141 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.02 compared to INR 0.05 a year ago. For the quarter, on consolidated basis, the company reported net sales/income from operations of INR 23.155 million compared to INR 49.190 million a year ago. Loss before interest and exceptional items was INR 10.213 million compared to INR 25.112 million a year ago. Loss before tax was INR 10.216 million compared to INR 25.141 million a year ago. Net loss after tax and extraordinary was INR 10.216 million compared to INR 25.141 million a year ago. Basic and diluted loss per share before and after extraordinary items was INR 0.02 compared to INR 0.05 a year ago.